Protalix BioTherapeutics Reports Second Quarter 2022 Financial and Business Results

Adella Miesner

Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel, Aug. 15, 2022 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, […]